0001127602-23-006515.txt : 20230222 0001127602-23-006515.hdr.sgml : 20230222 20230222165836 ACCESSION NUMBER: 0001127602-23-006515 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230218 FILED AS OF DATE: 20230222 DATE AS OF CHANGE: 20230222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANDINE MICHAEL J CENTRAL INDEX KEY: 0001235600 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 23654277 MAIL ADDRESS: STREET 1: 88 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 021394136 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2023-02-18 0001520262 Alkermes plc. ALKS 0001235600 LANDINE MICHAEL J 852 WINTER ST. WALTHAM MA 02451 1 SVP, Corp Dev., Alkermes, Inc. Ordinary Shares 2023-02-18 4 M 0 4361 A 236667 D Ordinary Shares 2023-02-18 4 F 0 2065 28.07 D 234602 D Ordinary Shares 2023-02-20 4 M 0 5354 A 239956 D Ordinary Shares 2023-02-20 4 F 0 2378 28.07 D 237578 D Ordinary Shares 2023-02-20 4 A 0 11770 A 249348 D Ordinary Shares 2023-02-20 4 F 0 5226 28.07 D 244122 D Ordinary Shares 2023-02-21 4 M 0 5825 A 249947 D Ordinary Shares 2023-02-21 4 F 0 2587 27.77 D 247360 D Restricted Stock Unit Award 2023-02-18 4 M 0 4361 D Ordinary Shares 4361 13084 D Restricted Stock Unit Award 2023-02-20 4 M 0 5354 D Ordinary Shares 5354 5354 D Restricted Stock Unit Award 2023-02-21 4 M 0 5825 D Ordinary Shares 5825 0 D Each restricted stock unit represents a contingent right to receive one ordinary share. These ordinary shares were acquired by the reporting person as a result of the vesting of performance-vesting restricted stock unit awards granted to the reporting person on February 20, 2020 with a three-year performance period that ended on December 31, 2022 (the "2020 PRSUs"). The vesting of this portion of the 2020 PRSUs was triggered by the determination of achievement of certain pre-specified performance goals and application of a total shareholder return modifier and represents the final vesting event under the 2020 PRSUs. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021. This award is fully vested in accordance with its terms. /s/ Shantale Greenson, attorney-in-fact for Michael J. Landine 2023-02-22